Characterization of in-stent neointimal tissue components following drug-eluting stent implantation according to the phase of restenosis using a 40-MHz intravascular ultrasound imaging system

Journal of Cardiology

Volumn 64, Issue 6, 2014, Pages 423-429

  Araki, Tadashi ^a   Nakamura, Masato ^a   Sugi, Kaoru ^a  

^a TOHO UNIVERSITY   (Japan)

Author keywords

Angina pectoris; Coronary artery disease; Drug eluting stent; In stent restenosis; Neoatherosclerosis

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIAC PATIENT; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; IN-STENT RESTENOSIS; INTRAVASCULAR ULTRASOUND; INTRAVASCULAR ULTRASOUND SYSTEM; MALE; NEOINTIMA; PERCUTANEOUS CORONARY INTERVENTION; RADIOFREQUENCY; STABLE ANGINA PECTORIS; TISSUE CHARACTERIZATION; CORONARY BLOOD VESSEL; DEVICES; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; POSTOPERATIVE PERIOD; RADIOGRAPHY; RESTENOSIS;

AGED; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY VESSELS; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; NEOINTIMA; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE PERIOD; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84926419452     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2014.03.001     Document Type: Article

References (24)

1. Morice M.C., Serruys P.W., Sousa J.E., Fajadet J., Ban Hayashi E., Perin M., Colombo A., Schuler G., Barragan P., Guagliumi G., Molnàr F., Falotico R. Randomized Study with the Sirolimus-Coated Bx Velocity Balloon-Expandable Stent in the Treatment of Patients with de Novo Native Coronary Artery Lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002, 346:1773-1780. RAVEL Study Group.
2. Stone G.W., Ellis S.G., Cox D.A., Hermiller J., O'Shaughnessy C., Mann J.T., Turco M., Caputo R., Bergin P., Greenberg J., Popma J.J., Russell M.E. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004, 350:221-231. Taxus-IV Investigators.
3. Lee M.S., Pessegueiro A., Zimmer R., Jurewitz D., Tobis J. Clinical presentation of patients with in-stent restenosis in the drug-eluting stent era. J Invasive Cardiol 2008, 20:401-403.
4. Dangas G.D., Claessen B.E., Caixeta A., Sanidas E.A., Mintz G.S., Mehran R. In-stent restenosis in the drug-eluting stent era. J Am Coll Cardiol 2010, 56:1897-1907.
5. Wessely R., Kastrati A., Schömig A. Late restenosis in patients receiving a polymer-coated sirolimus-eluting stent. Ann Intern Med 2005, 143:392-394.
6. Garcìa-Garcìa H.M., Gogas B.D., Serruys P.W., Bruining N. IVUS-based imaging modalities for tissue characterization: similarities and differences. Int J Cardiovasc Imaging 2011, 27:215-224.
7. Sathyanarayana S., Carlier S., Li W., Thomas L. Characterisation of atherosclerotic plaque by spectral similarity of radiofrequency intravascular ultrasound signals. EuroIntervention 2009, 5:133-139.
8. Matsuo S., Imai E., Horio M., Yasuda Y., Tomita K., Nitta K., Yamagata K., Tomino Y., Yokoyama H., Hishida A. GFR Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009, 53:982-992.
9. The thrombolysis in myocardial infarction (TIMI) trial. Phase 1 findings. TIMI study group. N Engl J Med 1985, 312:932-936.
10. Mehran R., Dangas G., Abizaid A.S., Mintz G.S., Lansky A.J., Satler L.F., Pichard A.D., Kent K.M., Stone G.W., Leon M.B. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 1999, 100:1872-1878.
11. Mintz G., Nissen S., Anderson W., Bailey S., Erbel R., Fitzgerald P., Pinto F., Rosenfield K., Siegel R., Tuzcu E., Yock P. American College of Cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2001, 37:1478-1492.
12. Virmani R., Kolodgie F.D., Farb A., Lafont A. Drug eluting stents: are human and animal studies comparable?. Heart 2003, 89:133-138.
13. Teramoto T., Ikeno F., Otake H., Lyons J.K., van Beusekom H.M., Fearon W.F., Yeung A.C. Intriguing peri-strut low-intensity area detected by optical coherence tomography after coronary stent deployment. Circ J 2010, 74:1257-1259.
14. Nakazawa G., Otsuka F., Nakano M., Vorpahl M., Yazdani S.K., Ladich E., Kolodgie F.D., Finn A.V., Virmani R. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. J Am Coll Cardiol 2011, 57:1314-1322.
15. Kang S.J., Mintz G.S., Akasaka T., Park D.W., Lee J.Y., Kim W.J., Lee S.W., Kim Y.H., Whan Lee C., Park S.W., Park S.J. Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation. Circulation 2011, 123:2954-2963.
16. Kang S.J., Mintz G.S., Park D.W., Lee S.W., Kim Y.H., Lee C.W., Han K.H., Kim J.J., Park S.W., Park S.J. Tissue characterization of in-stent neointima using intravascular ultrasound radiofrequency data analysis. Am J Cardiol 2010, 106:1561-1565.
17. Higo T., Ueda Y., Oyabu J., Okada K., Nishio M., Hirata A., Kashiwase K., Ogasawara N., Hirotani S., Kodama K. Atherosclerotic and thrombogenic neointima formed over sirolimus drug-eluting stent: an angioscopic study. JACC Cardiovasc Imaging 2009, 2:616-624.
18. Nakazawa G., Vorpahl M., Finn A.V., Narula J., Virmani R. One step forward and two steps back with drug-eluting-stents: from preventing restenosis to causing late thrombosis and nouveau atherosclerosis. JACC Cardiovasc Imaging 2009, 2:625-628.
19. Collet C.A., Costa J.R., Abizaid A., Chamié D., Staico R., Costa R., Siquera D., Obregon J., Feres F., Sousa A., Sousa J.E. Assessing the temporal course of neointimal hyperplasia formation after different generations of drug-eluting stents. JACC Cardiovasc Interv 2011, 4:1067-1074.
20. Kwon S.W., Kim B.K., Kim T.H., Kim J.S., Ko Y.G., Choi D., Jang Y., Hong M.K. Qualitative assessment of neointimal tissue after drug-eluting stent implantation: comparison between follow-up optical coherence tomography and intravascular ultrasound. Am Heart J 2011, 161:367-372.
21. Utsunomiya M., Hara H., Sugi K., Nakamura M. Relationship between tissue characterisations with 40MHz intravascular ultrasound imaging and slow flow during coronary intervention. EuroIntervention 2011, 7:340-346.
22. Araki T., Nakamura M., Utsunomiya M., Sugi K. Visualization of coronary plaque in arterial remodeling using a new 40-MHz intravascular ultrasound imaging system. Catheter Cardiovasc Interv 2013, 81:471-480.
23. Nagai H., Ishibashi-Ueda H., Fujii K. Histology of highly echolucent regions in optical coherence tomography images from two patients with sirolimus-eluting stent restenosis. Catheter Cardiovasc Interv 2010, 75:961-963.
24. Otake H., Shite J., Shinke T., Miyoshi N., Kozuki A., Kawamori H., Nakagawa M., Nagoshi R., Hariki H., Inoue T., Osue T., Taniguchi Y., Hiranuma N., Nishio R., Kinutani H., et al. Impact of stent platform of paclitaxel-eluting stents: assessment of neointimal distribution on optical coherence tomography. Circ J 2012, 76:1880-1888.